A grant from the Foundation for Sarcoidosis Research (FSR) will fund the development of a new mouse model of sarcoidosis, which could aid in understanding how the disease develops and ultimately serve as a platform for testing potential treatments. The FSR’s Small Grant program provides up to $25,000…

Over the past few weeks, I had appointments with both of my pulmonologists involving follow-up consults and pulmonary function tests (PFTs). My new pulmonologist specializes in sarcoidosis and pulmonary hypertension, making…

Although neurological symptoms are rare in people with sarcoidosis, physicians should consider neurosarcoidosis in cases of myelitis and hydrocephalus, as prompt steroid treatment can improve patient outcomes. The recommendation comes from researchers at the Jersey Shore University Medical Center in a recent case study, “Hydrocephalus…

A chronic health condition like pulmonary sarcoidosis can have a mental stranglehold on a person, causing fear, anxiety, and stress that we must learn to live with. Such a stranglehold can hold you hostage both mentally and physically.

Pediatric-onset sarcoidosis may require long-term treatment, and can be associated with severe consequences in adulthood, according to a French study. Of 52 adults with sarcoidosis as children, half were still being treated and four had uncontrolled disease, its researchers reported. The study, “Child–Adult Transition in Sarcoidosis: A…

This weekend I’ll be celebrating an anniversary. Actually, it’s more like a milestone. Although it seems peculiar to celebrate it, I’m doing so with plans to become a better person. This weekend marks the third anniversary of my first spontaneous pneumothorax…

New diagnostic guidelines for cardiac sarcoidosis yield a higher number of diagnoses and identify more cases of isolated cardiac sarcoidosis (iCS), according to a study in Japan. In cardiac sarcoidosis, inflammatory clusters of white blood cells — called granulomas — affect the heart but can also affect other…

Two years ago this week, I was in the hospital suffering from crepitus. I didn’t immediately know how serious the condition was, but it soon caused me to be intubated in the hospital’s ICU. The same hospital…

Protalix BioTherapeutics and SarcoMed USA have entered into a non-binding agreement related to the development and commercialization of PRX-110 (alidornase alfa) for pulmonary sarcoidosis and related diseases, according to a Protalix press release. PRX-110 is currently being developed by Protalix as a potential therapy for…

More than 20% of sarcoidosis patients show signs of an immune system response against aluminum, beryllium, zirconium, and silica, supporting the idea that these compounds may be involved in the development of the disease in a subgroup of patients, according to findings from a research study. The study, “…